Rochelle Walensky, MD, MPH

Sens. Johnson and Lee write to CDC Director Walensky and FDA Acting Commissioner Woodcock raising concerns about reports of adverse events following COVID-19 vaccination.

Sen. Johnson writes to Collins, Walensky, and Woodcock about vaccine safety monitoring systems described in the October 2020 VRBAC meeting.

Sen. Johnson writes to Collins, Walensky, Woodcock, Marks, and Shimabukuro about federal safety surveillance systems and reports of adverse events following COVID-19 vaccination.

Sen. Johnson writes to Woodcock and Walensky about specific "hot lots" of COVID-19 vaccines associated with increased reports of adverse events.

Sen. Johnson writes to Walensky reiterating outstanding requests for COVID-19 information including data on adverse events and vaccine lot variation.

Sen. Johnson writes to HHS Secretary Becerra, FDA Commissioner Califf, NIAID Director Fauci, and CDC Director Walensky highlighting more than 1 million VAERS reports of adverse events.

Sen. Johnson writes to Walensky requesting CDC produce vaccine safety data, including any EB data mining analyses created as part of its monitoring efforts.

Sen. Johnson writes to Walensky reiterating his June 23, 2022 request for vaccine safety data, including EB data mining analyses.

Sen. Johnson writes to Walensky in response to CDC producing only public Proportional Reporting Ratio analyses and failing to respond to requests for EB data mining analyses.

Sen. Johnson writes to Walensky reiterating requests for EB data mining analyses and other vaccine safety data first requested in June 2022.